Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|3 CitationsGLP-1 & Metabolic

SR-9011 (Rev-ErbA Agonist)

Also known as: Rev-ErbA Agonist, Circadian Metabolic Modulator

Dose Range
10–30 mgResearch range
0Typical research window: 10–30 mg37.5 mg

Studied in published research — not a medical recommendation. Primary protocol (Standard Protocol): 10-30 mg, 2-3x daily (short half-life).

Protocol at a Glance
How Often
Daily

2-3x daily (short half-life)

A Typical Run
8-12 weeks

Research-reported range (no primary dosing study). Very short half-life requires multiple daily doses

How It's Taken
Vial / Oral

Oral

Evidence
Clinical Trials

Published peer-reviewed research & clinical protocols

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

20 mg vial · 2 mL water · 0.5 mL syringe
Concentration: 10 mg in every mL (100 mcg per unit)
0u10u20u30u40u50u
Low end: 10 mg100 units
High end: 30 mg300 units

All U-100: 100 units = 1 mL. 2 doses in the vial at the low end (0 doses at the high end).

Track the doses you run

Save SR-9011 (Rev-ErbA Agonist) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

Research / Non-FDATier 3 — Translational Animal & Clinical Obs
Pharmacological Class
Oral Small-Molecule Metabolic & Nuclear Receptor Modulator
Administration Route
Oral capsule or liquid solution (Non-injectable small molecule)
2026 FDA & 503A Status
Unapproved investigational compound in the US; not listed on the FDA 503A Bulk Drug Substances positive list. Available for laboratory research with third-party HPLC + LC-MS COA verification.
WADA Sport Status
Strictly Prohibited at All Times — WADA Section S4.4 (Metabolic Modulators: AMPK / PPARδ / Rev-ErbA Agonists)
Evidence Tier
Tier 3 — Translational Animal & Clinical Obs: Replicated mammalian preclinical models plus extensive off-label physician & community protocol tracking

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. SR-9011 (Rev-ErbA Agonist) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

SR-9011 is a Rev-ErbAα/β agonist. It is NOT a peptide. It modulates circadian rhythm and metabolic genes. Popular for "exercise in a pill" effects and metabolic enhancement. Related to SR-9009 (Stenabolic).

Mechanisms of Action

  • Activates Rev-Erb receptors — regulates circadian rhythm
  • Increases metabolic rate and energy expenditure
  • Enhances exercise capacity in animal studies
  • May improve sleep-wake cycles

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Standard Protocol
animal study
10-30 mg2-3x daily (short half-life)8-12 weeksOralanimal—
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Metabolic, Hepatic & Incretin Safety Biomarker Panel (SR-9011 (Rev-ErbA Agonist))

Quantify visceral fat mobilization, insulin resistance reversal, hepatic steatosis (MASH) clearance, and pancreatic/renal safety during metabolic protocols.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

HbA1c & Fasting Insulin (HOMA-IR)

Day 0 + Wk 6–8

Why track at baseline: Measures baseline hyperinsulinemia and 90-day glycemic load prior to incretin or lipolytic initiation.

Week 6–8 check: Track rapid drop in Fasting Insulin (often 30%–50% reduction by Week 6–8) and normalizing HbA1c.

ALT, AST & GGT Liver Enzymes

Day 0 + Wk 6–8

Why track at baseline: Dual/triple agonists (Retatrutide, Mazdutide, Pemvidutide) mobilize 65%–80% of intrahepatic triglycerides.

Week 6–8 check: Confirm progressive reduction in ALT/AST (<25 U/L) as hepatic steatosis clears.

ApoB, Triglycerides & Advanced Lipid Panel

Day 0 + Wk 6–8

Why track at baseline: Quantifies atherogenic particle burden and VLDL triglyceride export before weight loss.

Week 6–8 check: Expect 20%–40% triglyceride drop and significant ApoB improvement alongside visceral fat loss.

Serum Lipase, Amylase & eGFR / Cystatin C

Day 0 + Wk 6–8

Why track at baseline: Essential safety screen for subclinical pancreatic inflammation and hydration/renal filtration.

Week 6–8 check: Ensure Lipase stays within reference range and eGFR remains stable with adequate electrolyte hydration.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •NOT A PEPTIDE — included for educational completeness
  • •Limited human data — primarily animal studies
  • •Short half-life makes dosing challenging
  • •Long-term safety unknown
  • •Not FDA approved
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get SR-9011 (Rev-ErbA Agonist), baseline labs & clinician oversight.

Compare all verified suppliers ↑
50% OFF AUTO-APPLIEDFrom $0.30/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR
FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.